AI-enabled digital stethoscope for atrial fibrillation and heart failure detection.
FDA cleared, including a specific clearance for heart-failure detection.
Vendor press release citing telehealth deployment ‘powering virtual cardiac and pulmonary exams for health systems operating over 800 US hospitals’, plus a named rural use case (Wayne General Hospital, Mississippi).
The named rural deployment (Wayne General Hospital) is a real, identifiable site, though the announcement itself is vendor-distributed — treat the 800-hospital figure as vendor-reported until independently confirmed.
Vendor claims reach across health systems operating 800+ US hospitals, with a concrete named example in an under-resourced rural setting (Mississippi) — a useful equity-of-access example.
The 800-hospital figure is vendor-reported; the rural use case is the more concretely verifiable part of the claim.
This profile is not medical advice or an endorsement. Hospitals should perform their own due diligence (regulatory compliance, GDPR, cybersecurity, integration, local clinical validation). How we evaluate
Every profile documents the precise indication, regulatory status, vendor-supported and independent evidence, real-world deployment, limits and dated sources.
A independent systematic review or prospective multicentre study · B at least one independent peer-reviewed study · C peer-reviewed, vendor-supported · D vendor claims only.
Vendors, authors and clinicians can request a correction. Corrections are dated on the profile.